Drugs of Abuse in the Future

References

• Elliott H. W., Parker K. D., Wright J. A., Nomof N. Actions and metabolism of heroin administered by continuous intravenous infusion to man. Clin. Pharm. Therap. 1971; 12(5)806
   PubMed Web of Science ®Google Scholar
• Davidow B., Li Petri N., Quame B. A thin layer chromatographic screening procedure for detecting drug abuse. Am. J. Clin. Pathol. 1968; 50: 714
   Web of Science ®Google Scholar
• Mule S. J. Routine identification of drugs of abuse in human urine. I. Application of fluorometry, thin‐layer and gas‐liquid chromatography. J. Chrom. 1971; 55: 255
   PubMed Web of Science ®Google Scholar
• MacLean D. E., Pournelle J. E. Feasibility of synthetic substitutes for heroin. An analysis of economic factors affecting illegal production. 1972; 35, Unpublished monograph, (Ref: Anesthesia Research Facility, Los Angeles County Department of Hospitals, Rancho Los Amigos Hospital, Downey, California)
   Google Scholar
• Bentley K. W., Hardy D. G., Crocker H. P., Haddlesey D. I., Mayor P. A. Novel analgesics and molecular rearrangements in the morphine‐thebaine group. VI. Base‐catalyzed rearrangements in the 6–14‐endo‐etheno‐tetrahydrothebaine series. J. Am. Chem. Soc. 1967; 89: 3312
   PubMed Web of Science ®Google Scholar
• Janssen P. A. J., van der Eycken C. A. M. The Chemical Anatomy of Potent Morphine‐like Analgesics. Drugs Affecting the Central Nervous System, A. Burger. Dekker, New York 1968; 25–60
   Google Scholar
• United Nations Economic and Social Council, Commission on Narcotic Drugs. October 31, 1967; 1–2, Report of the Division of Narcotic Drugs for the period 1 October 1966 to 31 October 1967. E/CN.7/503. Annex
   Google Scholar
• Bentley K. W., Boura A. L. A., Fitzgerald A. E., Hardy D. G., McCoubrey A., Aikman M. L., Lister R. E. Compounds possessing morphine‐antagonizing or powerful analgesic properties. Nature 1965; 206: 102
   PubMed Web of Science ®Google Scholar
• Boura A. L. A. personal communication to Lowe, G. and Williams, D. I., Some effects of a hallucinogenic compound [Cyprenorphine Hydrochloride; M‐285] on the Light‐reinforced Behaviour of Rats. Nature 1969; 224: 1226
   PubMed Web of Science ®Google Scholar
• Maugh T. H. Narcotic antagonists: The search accelerates. Science 1972; 177: 249
   PubMed Web of Science ®Google Scholar
• Grewe R. Das Problem der Morphin‐Synthese. Naturwissenschaften 1946; 33: 333
   Web of Science ®Google Scholar
• Grewe R., Mondon A. Synthesen in der Phenanthren‐Reihe. VI. Mitteil.: Synthese des Morphinans. Ber. Deut. Chem. Gest. 1948; 81: 279
   Google Scholar
• Schneider O., Grussner A. Synthese von Oxymorphinanen. Hel. Chim. Acta 1949; 32: 821
   PubMed Web of Science ®Google Scholar
• Schneider O., Hellerbach J. Synthese von Morphinanen. Helv. Chim. Acta 1950; 33: 1437
   Web of Science ®Google Scholar
• Seki I., Tagaki H., Kobayashi S. Pharmacological studies on morphine derivatives. III. Chemical structure‐activity relations of 14‐hydroxymorphine derivatives. J. Pharm. Soc. Japan 1964; 84: 280
   PubMedGoogle Scholar
• Eddy N. B., Besendorf H., Pellmont B. Synthetic analgesics. Aralkyl substitution on nitrogen of morphinan. Bull. Narcotics U.N. Dept. Social Affairs 1958; 10: 23
   Google Scholar
• Janssen P. A. J. 1966, unpublished data, quoted in Ref. [6]
   Google Scholar
• May E. L., Murphy J. G. Structures related to morphine. III. Synthesis of a analog of N‐methylmorphinan. J. Org. Chem. 1955; 20: 257
   Web of Science ®Google Scholar
• May E. L., Sargent L. J. Analgesics, G. de Stevens. Academic, New York 1965; 123–177
   Google Scholar
• Fraser H. F., Rosenberg D. E. Studies on the human addiction liability of 2'‐hydroxy‐5,9‐dimethyl‐2‐(3,3‐dimethylallyl)‐6,7‐benzomorphan (WIN 20,228): A weak narcotic antagonist. J. Pharm. Exptl. Therap. 1964; 143: 149
   PubMed Web of Science ®Google Scholar
• Inciardi J. A., Chambers C. D. Patterns of pentazocine abuse and addiction. N.Y. State J. of Med. 1971; 1727–1733
   PubMedGoogle Scholar
• Roth C. H., Trout M. E. Medico‐legal implications of careless adverse reaction reporting‐case reports of alleged pentazocine dependence. Hospital Formulary Management 1970; 5: 13
   Google Scholar
• de Nosaquo N. The hallucinatory effect of pentazocine (Talwin). JAMA 1969; 210: 502
   PubMed Web of Science ®Google Scholar
• Abuzzahab F. S. The antidepressant properties of cyclazocine. Am. J. Clin. Res. 1970; 1: 9
   Google Scholar
• Eisleb O., Schaumann O. Dolantin, ein neuratiges Spasmolytikum und Analgetikum (Chemisches und Pharmakologisches). Deutsche medizinische Wochenschrift 1939; 65: 967
   Google Scholar
• Lasagna L., Beecher H. K. The analgesic effectiveness of codeine and meperidine (Demerol). J. Pharm. Exptl. Therap. 1954; 112: 306
   PubMed Web of Science ®Google Scholar
• Eddy N. B., Halbach H., Braenden O. J. Synthetic substances with morphine‐like effect. Bull. W.H.O. 1957; 17: 569
   PubMedGoogle Scholar
• Burger A. Medicinal Chemistry. Wiley‐Interscience, New York 1970; 1338
   Google Scholar
• Carabateas P. M., Grumbach L. Strong analgesics some 1‐substituted 4‐phenyl‐4‐propionoxypiperidines. J. Med. Pharm. Chem. 1962; 5: 913
   Google Scholar
• King A. G. Perinatal hypoxia caused by obstetrical analgesia and its avoidance by use of prodine. Am. J. Obstet. Gynecol. 1956; 71: 1001
   PubMed Web of Science ®Google Scholar
• Kleiderer E. C., Rice J. B., Conquest V., Williams J. H. Report No. PP‐981, Office of the Publication Board. U.S. Dept. of Commerce, Washington, D.C. 1945
   Google Scholar
• Bockmühl M., Ehrhart G. Uber eine Neue Klasse von Spasmolytisch und Analgetisch Wirkenden Verbindugen. I. Ann. 1948; 561
   Google Scholar
• Cusic J. W. An improvement on the process for making amidone. J. Am. Chem. Soc. 1949; 71: 3546
   Web of Science ®Google Scholar
• Eddy N. B., May E. L., Mossettig E. Chemistry and pharmacology of the methadols and acetylmethadols. J. Org. Chem. 1952; 17: 321
   Web of Science ®Google Scholar
• Jaffe J. H., Schuster C. R., Smith B. B., Blanchley P. H. Comparison of acetylmethadol and methadone in the treatment of long term heroin users. A pilot study. JAMA 1970; 211: 1834
   PubMed Web of Science ®Google Scholar
• Wright W. B., Brabander H. J., Hardy R. A. N‐(tert‐Aminoalkyl)‐propionanilides: A new series of potent analgesics. J. Am. Chem. Soc. 1959; 81: 1518
   Web of Science ®Google Scholar
• Adamson D. W., Green A. F. A new series of analgesics. Nature 1950; 165: 122
   PubMed Web of Science ®Google Scholar
• Flintan P., Keele C. A. Analgesics and other actions of some dithienylbutenylamine compounds in man. Brit. J. Pharmacol. 1954; 9: 106
   Web of Science ®Google Scholar
• Fraser H. F., Isbel H., Wolback R. Bull. Addiction and Narcotics Addendum 1960; 2: 35
   Google Scholar
• Hunger A., Kebrle J., Rossi A., Hoffmann K. Benzimidazol‐Derivate und verwandte Heterocyclen. II. Synthese von 1‐Aminoalkyl‐2‐benzyl‐benzimidazolen. Helv. Chim. Acta 1960; 43: 800, Synthese von 1‐Aminoalkyl‐2‐benzyl‐nitrobenzimidazolen, ibid., 43, 1032 (1960)
   Web of Science ®Google Scholar
• Federal Register July 7, 1971; 12734
   Google Scholar
• Finlator J. Open letter to pharmacists, United States Dept. of Justice (Bureau of Narcotics and Dangerous Drugs). Aug. 11, 1971
   Google Scholar
• Aldrich Handbook of Organic Chemicals. Aldrich Chemical Company, Milwaukee, Wisconsin 1972
   Google Scholar
• Cutting W. C. Cutting's Handbook of Pharmacology. Meredith, New York 1969; 512
   Google Scholar
• Clarke E. G. C. The identification of amphetamine type drugs. J. Forensic Sci. Soc. 1967; 7: 31
   PubMedGoogle Scholar
• Prinzmetal M., Bloomberg W. The use of benzedrine for the treatment of narcolepsy. JAMA 1935; 105: 2051
   Google Scholar
• Dagirmanjian R., Boyd E. S. Some pharmacological effects of two tetrahydrocannabinols. J. Pharmacol. Exptl. Therap. 1962; 135: 25
   PubMed Web of Science ®Google Scholar
• Ellison T., Levy L., Bolger J. W., Okun R. The metabolic fate of 3H‐fenetyline in man. Eur. J. Pharm. 1970; 13: 123
   PubMed Web of Science ®Google Scholar
• Remberg G., Marsel J., Doring G., Spiteller G. Amphetamin ein Metabolit von AN‐1. Ein Beitrag zur Problematik von Dopinganalysen. Arch. Toxikol. 1972; 29: 153
   PubMedGoogle Scholar
• Slechtova R., Chundela B. Isolation and identification of Amphetamine—the metabolic product of aponeuron, captagon, and prenylamin. Activ. Nerv. Suppl. 1972; 14: 119
   PubMedGoogle Scholar
• Paris R. Abyssinian tea (Catha edulis Forssk, Celastraceae). Bull. Narcotics 1958; 10(2)29
   Google Scholar
• Angrist B. M., Schweitzer J. W., Gershon S., Friedhoff A. J. Mephentermine psychosis: misuse of the Wyamine inhaler. Am. J. Psychiat. 1970; 126: 149
   Google Scholar
• Anderson E. D. Propylhexedrine (Benedrex) psychosis. New Zealand Med. J. 1970; 71: 302
   PubMedGoogle Scholar
• Biel J. H. Stimulants: Structure‐Activity Relationships. Principles of Psychopharmacology, W. G. Clark, J. del Giudice. Academic, New York 1970; 327–334
   Google Scholar
• Chernov H. L., Wilson D. E., Partyka D. A., Bernard P. S., Huebner C. F. Pharmacological properties of Su‐19789B. A unique central nervous system stimulant. Arch. Int. Pharm. 1970; 184: 34
   PubMedGoogle Scholar
• Gott P. H. Cyclizine toxicity—international drug abuse of a proprietary antihistamine. New Engl. J. Med. 1968; 279: 596
   Web of Science ®Google Scholar
• Malcolm R., Miller W. C. Dimenhydrinate (Dramamine) abuse: Hallucinogenic experiences with a proprietary antihistamine. Am. J. Psychiat. 1972; 128: 1012
   PubMed Web of Science ®Google Scholar
• Stockley I. H. Basic principles of drug interaction. Chem. in Britain March, 1972; 114–118
   PubMedGoogle Scholar
• Robinson A. E. Forensic toxicology of psycho‐active drugs. Chem. in Brit. March, 1972; 118
   PubMedGoogle Scholar
• Nakamura G. R., Parker B. P. Assay of cocaine in the presence of procaine and quinine by column chromatography. J. Chrom. 1970; 52: 107
   PubMed Web of Science ®Google Scholar
• Hopkins J. Cocaine: A flash in the pan, a pain in the nose. Rolling Stone April 29, 1971; 1–6
   Google Scholar
• MacLean D. E. 1972, personal communication to A. T. Shulgin
   Google Scholar
• Willstätter R., Bommer M. Eine Vollständige Synthese von r‐Ekgonin und von Tropinon. Ann. 1920; 422: 15
   Google Scholar
• Liebermann C. Ueber das Benzoyl‐ψ‐tropein, ein Nebenalkaloid der Javanischen Cocoblätter. Ber. 1891; 24: 2336
   Google Scholar
• Frederick D., Jr. A 'downer with a difference' is newest hot item in street drugs. National Observer September, 1972, (late)
   Google Scholar
• Zito T. The Rush for Tranquility, Washington Post Service, in the San Francisco Chronicle. Sunday Punch. June 18, 1972; 5
   Google Scholar
• Zwerdling D. Hottest drug on the street, a worried look at the new ‐heroin for lovers,' Washington Post Service, in the San Francisco Chronicle. Nov. 13, 1972; 15
   Google Scholar
• Kacker I. K., Zaheer S. H. Potential analgesics. Part I. Synthesis of substituted 4‐quinazolones. J. Indian Chem. Soc. 1951; 28: 344
   Web of Science ®Google Scholar
• Gujral M. L., Saxena P. N., Tiwari R. S. Comparative evaluation of quinazolones: A new class of hypnotics. Indian J. Med. Res. 1955; 43: 637
   PubMedGoogle Scholar
• Federal Register May 11, 1972; 9500
   Google Scholar
• Boltze K. H., Dell H. D., Lehwald H., Lorenz D., Rüberg‐Scheer M. Substituerte Chinazolinone‐(4) als Hypnotica und Antikonvulsia. Arzneimittel‐Forschung 1963; 13: 688
   PubMedGoogle Scholar
• Boissier J. R., Dumont C., Ratouis R. Pharmacological significance of substituents on the phenyl nucleus of 2‐methyl‐3‐phenyl‐4‐quinazolone. Thérapie 1967; 22: 129
   Google Scholar
• Wandreg D., Leutner V. Neuro‐psychopharmaca in klinik und praxis, F. K. Schattauer, Stuttgart 1965
   Google Scholar
• Saito C., Sakai S., Yukawa Y., Yamamoto H., Takagi H. Pharmacological studies on 2‐methyl‐3(2'‐methyl‐4'‐chlorophenyl)‐5‐chloro‐4(3H)‐quinazolinone (SL‐164). Arzneimittel‐Forschung 1969; 19: 1945
   PubMed Web of Science ®Google Scholar
• Barten H. H. Toxic psychosis with transient dysmnestic syndrome following withdrawal from Valium. Am. J. Psychiat. 1965; 121: 1210
   PubMed Web of Science ®Google Scholar
• Relkin R. Death following withdrawal of diazepam. N.Y. State J. Med. 1966; 66: 1770
   PubMedGoogle Scholar
• Maddox V. H., Godefroi E. F., Parcell R. F. The synthesis of phencyclidine and other 1‐arylcyclohexylamines. J. Med. Chem. 1965; 8: 230
   PubMed Web of Science ®Google Scholar
• Godefroi E. F., Maddox V. H., Woods H., Parcell R. F. Process for producing a depressant‐like effect on the central nervous system, U.S. Patent. #3,097,136
   Google Scholar
• Rappolt R. T. Apparent antagonism of ergotamine on the gravid uterus by LSD‐25. Intern. Microfilm J. Legal Med. 1970; 15: 3, Europ. J. of Toxicol., Nov.‐Dec. (1970)
   Google Scholar
• Rothlin E. Pharmacology of lysergic acid diethylamide and some of its related compounds. J. Pharm. Pharmacol. 1957; 9: 569
   PubMed Web of Science ®Google Scholar
• Cerletti A. Neuro‐psychopharmacology, P. B. Bradley, P. Deniker, C. Radouco Thomas. Elsevier, Amsterdam 1959; 117
   Google Scholar
• Hofmann A. The active principles of the seeds of Rivea Corymbosa and Ipomoca violacea, Botanical Museum Leaflets. Harvard University. 1963; 20: 194
   Google Scholar
• Szara S. The Comparison of the Psychotic Effects of Tryptamine Derivatives with the Effects of Mescaline and LSD‐25 in Self‐experiments. Psychotropic Drugs, S. Garattini, V. Ghetti. Elsevier. 1957; 460–467
   Google Scholar
• Szara S. DMT (N,N‐Dimethyltryptamine) and Homologues: Clinical and Pharmacological Considerations. Psychotomimetic Drugs, D. Efron. Raven Press, New York 1970; 275–286
   Google Scholar
• Naranjo C. Psychotropic Properties of the Harmala Alkaloids. Ethnopharmacologic Search for Psychoactive Drugs, D. H. Efron. Public Health Service Publication #1645, 1967; 385–391
   Google Scholar
• Shulgin A. T. The six trimethoxyphenylisopropylamines (trimethoxy‐amphetamines). J. Med. Chem. 1966; 9: 445
   PubMedGoogle Scholar
• Shulgin A. T., Sargent T., Naranjo C. Structure‐activity relationships of one‐ring psychotomimetics. Nature 1969; 221: 537
   PubMed Web of Science ®Google Scholar
• Shulgin A. T., Sargent T., Naranjo C. 4‐Bromo‐2,5‐dimethoxy‐phenylisopropylamine, a new centrally active amphetamine analog. Pharmacology 1971; 5: 103
   PubMed Web of Science ®Google Scholar
• Federal Register May 12, 1972; 9545–9557
   Google Scholar
• Anderson F. E. 1973, personal communication to A. T. Shulgin
   Google Scholar
• Abood L. G. The Psychotomimetic Glycolate Esters. Drugs Affecting the Central Nervous System, A. Burger. Dekker, New York 1968; 127–167
   Google Scholar
• Murphree H. B., Dippy R. H., Jenney E. H., Pfeiffer C. C. Effects in normal man of alpha‐methyltryptamine and alphaethyl‐tryptamine. Clin. Pharmacol. Therap. 1961; 2: 722
   PubMed Web of Science ®Google Scholar